CUVL

Clinuvel Pharmaceuticals Ltd

Healthcare · Biotechnology

$283.22 sample

+2.06 (+0.73%) 1D

Market cap

$650.9B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-22

Alerts

8

Price$283.22 +24.59% 3M daily closessample

283.22226.38

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider buy: EVP, Operations
Sep 22SECForm 144 filed
Sep 16INSInsider buy: Director
Sep 07INSInsider sell: Chief Financial Officer
Aug 31INSInsider sell: EVP, Operations
Aug 26INSInsider sell: Chief Executive Officer
Aug 20SEC10-Q filed
Aug 17INSInsider sell: General Counsel

Sign up to see the real CUVL record →

Company facts

SEC EDGAR registration

Name: Clinuvel Pharmaceuticals Ltd
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +21sample, -100 to +100
Reporting currency: USD

Who is positioning in CUVL

sample

Insiders: 22 insider transactions over 90 days, net selling, $353.7M
Congress: 2 members traded over 90 days
Institutions · 13F: 44 funds hold $13.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.4B +13.3% y/y

Q4 2024Q3 2026

Inventory$10.6B +17.7% y/y

Q4 2024Q3 2026

Accounts receivable$8.3B +18.7% y/y

Q4 2024Q3 2026

Total debt$20.6B +12.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $256.2B +10.2% 3M
Sample peer B: $536.2B +14.7% 3M
Sample peer C: $137.5B +6.7% 3M
Sample peer D: $643.5B +4.6% 3M
Sample peer E: $314.0B +16.0% 3M